Vijay

#IntegratedCare #AdvancedPractice #Asthma #COPD #Bronchiectasis #Oxygen #NIV #BreathingDysfunction #Leadership #Research #RespEd |Views my own|

[Don Sin @donsin4]

transdermal fentanyl or oral morphine compared to placebo for persistent dyspnoea in #COPD. No significant differences for dyspnoea, sleep, health status, or anxiety. More vomiting with opioids. Re-think use of opioids for dyspnea in #COPD https://t.co/12tYYHOfG9

[Nick Hopkinson @COPDdoc]

New airway clearance videos for people with lung disease from Asthma + Lung UK https://t.co/n0n8Jj9TCq #RespEd #COPD #Bronchiectasis

[James D Chalmers @ProfJDChalmers]

New research confirms what we've suspected for a long time - the "test dose" of hypertonic saline in clinic does nothing except test the variability of spirometry as a measure
Most people who failed the test passed a repeat. Most people who couldn't tolerate HTS long term passed the test first time
https://t.co/3JP887FWp8

[ERS publications @ERSpublications]

ERJ Open Research: Dysphagia significantly increases the risk and frequency of acute exacerbations of COPD (rate ratio 2.37). Routine swallowing screening should be considered in COPD management to mitigate this modifiable risk factor. https://t.co/Zir5KhU1GB

[ERS publications @ERSpublications]

ERJ Open Res: ViP-Cough, a single-session virtual group intervention, is a promising, scalable and low-cost approach to delivering nonpharmacological cough therapy. These preliminary findings support further evaluation in a randomised controlled trial. https://t.co/Twq5ITz0FK

[NEJM @NEJM]

For patients with acute hypoxemic respiratory failure, whether high-flow oxygen is superior to standard oxygen in reducing mortality is unclear. Research findings from the SOHO trial are summarized in a new Quick Take video. https://t.co/CdjTWMO61g

[ThoraxBMJ @ThoraxBMJ]

Thorax Editorial: The goal of the tobacco endgame is that no one starts to smoke, that everyone who smokes is supported to quit and that reductions in consumption and profitability mean that the tobacco industry, which continues to be the main barrier to progress, ceases to be commercially viable.
https://t.co/VkjITrAEYm

[Vijay @ChestPhysio]

Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial - The Lancet Respiratory Medicine https://t.co/HMKwa1LLYK

[James D Chalmers @ProfJDChalmers]

The first approved treatment for bronchiectasis ever in the UK. MHRA approved brensocatib for bronchiectasis patients aged 12 and over
https://t.co/hTvrBUdJqP

[Imperial NHS 💙 @ImperialNHS]

A large NHS study published in @TheLancet has found that a new AI-enabled stethoscope designed to detect serious heart conditions spots them faster and more frequently in primary care. Read our news story. ➡️ https://t.co/wetAh8hh7F

@ImperialNHLI | @ImperialBRC

[NICE @NICEComms]

Thousands of people with COPD are set to benefit from a new targeted treatment that can be taken at home.

Learn more about dupilumab:
https://t.co/VBFGvvh6Wg

[ERS publications @ERSpublications]

European Respiratory Journal: This study shows objective evidence of the adverse physiological, imaging and molecular changes in cannabis smoke-exposed small airways that may contribute to long-term respiratory morbidity https://t.co/LeEFwaaEm2

[NHS England @NHSEngland]

Thank you to all our incredible NHS staff working over the Christmas period 💙

From nurses, doctors and midwives to paramedics, pharmacists and porters, thank you for continuing to care for our loved ones each and every day.

[Chartered Society of Physiotherapy (CSP) @thecsp]

Major breakthrough on safe staffing levels for AHPs

‘Your action helped make this happen, now your evidence can help ensure the final guidance truly reflects the needs of physiotherapy and wider AHP services.’

https://t.co/8ocYaYD1w6

[Chartered Society of Physiotherapy (CSP) @thecsp]

A simple twist left Rajinder crawling in pain.

He thought that was the rest of his life, until physio changed everything.

Lina’s tailored exercise plan got him back to work and back on his feet.

'I don't know where I'd be without it'.

#RightToRehab #PhysioGivesBack

[Chartered Society of Physiotherapy (CSP) @thecsp]

'It’s shocking that rehabilitation space continues to be sidelined and routinely taken away from physiotherapy teams.' @SHazzard

The Guardian reports on our latest survey, which revealed the extent of the loss of rehabilitation space.

#RightToRehab
https://t.co/4pdUo0JuyW

[NEJM @NEJM]

Original Article: Hypertonic Saline or Carbocisteine in Bronchiectasis (CLEAR trial) https://t.co/FleRvkTPUf

Editorial: Time to Reconsider Mucoactive Agents for Airway Clearance https://t.co/r5hozIXKw9

#ERSCongress | @EuroRespSoc

[JAMA Network Open @JAMANetworkOpen]

RCT: #Pulmonary rehabilitation using minimal equipment was noninferior to rehabilitation with specialist gym equipment in improving exercise capacity, dyspnea, and quality of life. https://t.co/lEiV8bhMow

[Paul Pfeffer @DoctorPfeff]

@ImogenSkene And to provide patient-friendly education on why we might advise changes to inhaled therapy. @NHSBartsHealth @NELHCP https://t.co/WnvJY0cQnB

[Paul Pfeffer @DoctorPfeff]

Clear association between frequent SABA use and acute cardiovascular events in both patients with asthma/COPD and those without. Salbutamol is not a benign medication that can be taken excessively without any risks. https://t.co/ey4KoFKDpc